Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Nifeviroc (Synonyms: TD-0232, TD0232)

Catalog No. T28171 Copy Product Info
Purity: 98.14%
🥰Excellent
Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection.

Nifeviroc

Copy Product Info
🥰Excellent
Catalog No. T28171
Synonyms TD-0232, TD0232

Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection.

Nifeviroc
Cas No. 934740-33-7
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$132-In Stock
5 mg$328-In Stock
10 mg$529-In Stock
25 mg$846-In Stock
50 mg$1,460-In Stock
100 mg$1,550-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.14%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection.
Targets&IC50
CHO cells:2.9 nM
In vitro
Nifeviroc is a specific HIV-1 entry inhibitor that works only by antagonizing CCR5 and not CXCR4. [1]
SynonymsTD-0232, TD0232
Chemical Properties
Molecular Weight590.71
FormulaC33H42N4O6
Cas No.934740-33-7
SmilesO[C@@]1(C2=CC=CC=C2)[C@H](CN(C1)C(C3CCCC3)=O)CN4CCC(CC4)N(CC=C)C(OCC5=CC=C(C=C5)[N+]([O-])=O)=O
Relative Density.1.28 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (135.43 mM), Sonication is recommended.
H2O: 80 mg/mL (135.43 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (5.59 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM1.6929 mL8.4644 mL16.9288 mL84.6439 mL
5 mM0.3386 mL1.6929 mL3.3858 mL16.9288 mL
10 mM0.1693 mL0.8464 mL1.6929 mL8.4644 mL
20 mM0.0846 mL0.4232 mL0.8464 mL4.2322 mL
50 mM0.0339 mL0.1693 mL0.3386 mL1.6929 mL
100 mM0.0169 mL0.0846 mL0.1693 mL0.8464 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nifeviroc | purchase Nifeviroc | Nifeviroc cost | order Nifeviroc | Nifeviroc chemical structure | Nifeviroc in vitro | Nifeviroc formula | Nifeviroc molecular weight